VIVUS (VVUS) Inks Qsymia Deal with MEDCO; 'Executing Well' Says Analyst
Tweet Send to a Friend
This morning VIVUS Inc. (Nasdaq: VVUS) said Qsymia was added to MEDCO national formulary in a tier-3 position with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
